Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Livomitra is an Ayurvedic herbal syrup developed and marketed by Navil Laboratories for supporting liver health and improving digestion. It is formulated with a blend of traditional hepatoprotective and immunomodulatory herbs, including Bhuiamalki (*Phyllanthus niruri*), Kalmegh (*Andrographis paniculata*), Bhringraj (*Eclipta prostrata*), Kasani (*Cichorium intybus*), Giloy (*Tinospora cordifolia*), and Katuki (*Picrorhiza kurroa*). The syrup is indicated for managing liver conditions such as hepatitis, non-alcoholic fatty liver disease (NAFLD), and chronic cholecystitis. It works by protecting liver cells from toxins and infections, stimulating bile secretion and flow to aid digestion, reducing gastrointestinal discomfort like bloating, and naturally stimulating appetite.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Livomitra.